Northern Trust’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Sell |
917,137
-134,698
| -13% | -$427K | ﹤0.01% | 2953 |
|
|
2025
Q4 | $4.21M | Sell |
1,051,835
-82,366
| -7% | -$458K | ﹤0.01% | 2573 |
|
|
2025
Q3 | $9.6M | Buy |
1,134,201
+8,511
| +0.8% | +$82.6K | ﹤0.01% | 2132 |
|
|
2025
Q2 | $12.7M | Sell |
1,125,690
-77,811
| -6% | -$715K | ﹤0.01% | 1925 |
|
|
2025
Q1 | $11.4M | Buy |
1,203,501
+8,637
| +0.7% | +$87.2K | ﹤0.01% | 1963 |
|
|
2024
Q4 | $13.4M | Buy |
1,194,864
+17,050
| +1% | +$300K | ﹤0.01% | 1951 |
|
|
2024
Q3 | $33.3M | Sell |
1,177,814
-12,431
| -1% | -$320K | 0.01% | 1300 |
|
|
2024
Q2 | $22.8M | Sell |
1,190,245
-10,553
| -0.9% | -$269K | ﹤0.01% | 1471 |
|
|
2024
Q1 | $39.4M | Sell |
1,200,798
-46,544
| -4% | -$1.49M | 0.01% | 1145 |
|
|
2023
Q4 | $41.2M | Buy |
1,247,342
+29,616
| +2% | +$838K | 0.01% | 1143 |
|
|
2023
Q3 | $33.2M | Buy |
1,217,726
+29,692
| +2% | +$825K | 0.01% | 1207 |
|
|
2023
Q2 | $36M | Buy |
1,188,034
+223,803
| +23% | +$7.24M | 0.01% | 1187 |
|
|
2023
Q1 | $31.3M | Buy |
964,231
+4,988
| +0.5% | +$158K | 0.01% | 1256 |
|
|
2022
Q4 | $26.9M | Buy |
959,243
+3,967
| +0.4% | +$114K | 0.01% | 1349 |
|
|
2022
Q3 | $34.3M | Sell |
955,276
-9,298
| -1% | -$328K | 0.01% | 1104 |
|
|
2022
Q2 | $29.6M | Buy |
964,574
+8,008
| +0.8% | +$233K | 0.01% | 1256 |
|
|
2022
Q1 | $30.9M | Sell |
956,566
-38,151
| -4% | -$999K | 0.01% | 1372 |
|
|
2021
Q4 | $27.5M | Buy |
994,717
+7,563
| +0.8% | +$217K | ﹤0.01% | 1550 |
|
|
2021
Q3 | $30.6M | Sell |
987,154
-10,226
| -1% | -$246K | 0.01% | 1469 |
|
|
2021
Q2 | $21.1M | Buy |
997,380
+152,135
| +18% | +$3.05M | ﹤0.01% | 1851 |
|
|
2021
Q1 | $17.1M | Sell |
845,245
-78,764
| -9% | -$1.5M | ﹤0.01% | 1944 |
|
|
2020
Q4 | $14.8M | Sell |
924,009
-43,371
| -4% | -$573K | ﹤0.01% | 2002 |
|
|
2020
Q3 | $12M | Sell |
967,380
-41,828
| -4% | -$492K | ﹤0.01% | 1995 |
|
|
2020
Q2 | $7.19M | Sell |
1,009,208
-87,449
| -8% | -$586K | ﹤0.01% | 2300 |
|
|
2020
Q1 | $5.96M | Buy |
1,096,657
+34,354
| +3% | +$307K | ﹤0.01% | 2193 |
|
|
2019
Q4 | $9.62M | Sell |
1,062,303
-101,504
| -9% | -$825K | ﹤0.01% | 2204 |
|
|
2019
Q3 | $8.37M | Buy |
1,163,807
+146,658
| +14% | +$1.05M | ﹤0.01% | 2258 |
|
|
2019
Q2 | $8.09M | Buy |
1,017,149
+9,393
| +0.9% | +$111K | ﹤0.01% | 2282 |
|
|
2019
Q1 | $12.7M | Sell |
1,007,756
-80,870
| -7% | -$1.28M | ﹤0.01% | 1994 |
|
|
2018
Q4 | $21.7M | Buy |
1,088,626
+9,342
| +0.9% | +$216K | 0.01% | 1515 |
|
|
2018
Q3 | $30.7M | Buy |
1,079,284
+51,785
| +5% | +$1.24M | 0.01% | 1435 |
|
|
2018
Q2 | $21.6M | Buy |
1,027,499
+193,330
| +23% | +$3.66M | 0.01% | 1724 |
|
|
2018
Q1 | $11.9M | Buy |
834,169
+16,912
| +2% | +$242K | ﹤0.01% | 2059 |
|
|
2017
Q4 | $10.1M | Buy |
817,257
+103,855
| +15% | +$1.46M | ﹤0.01% | 2183 |
|
|
2017
Q3 | $12.7M | Buy |
713,402
+149,178
| +26% | +$3.07M | ﹤0.01% | 2042 |
|
|
2017
Q2 | $14.3M | Buy |
564,224
+344,190
| +156% | +$8.28M | ﹤0.01% | 1928 |
|
|
2017
Q1 | $4.91M | Buy |
220,034
+35,286
| +19% | +$677K | ﹤0.01% | 2562 |
|
|
2016
Q4 | $2.73M | Buy |
184,748
+8,079
| +5% | +$159K | ﹤0.01% | 2916 |
|
|
2016
Q3 | $4.35M | Buy |
176,669
+15,593
| +10% | +$365K | ﹤0.01% | 2598 |
|
|
2016
Q2 | $3.09M | Buy |
161,076
+21,144
| +15% | +$290K | ﹤0.01% | 2785 |
|
|
2016
Q1 | $1.48M | Buy |
139,932
+1,834
| +1% | +$18.9K | ﹤0.01% | 3120 |
|
|
2015
Q4 | $1.67M | Buy |
138,098
+110,892
| +408% | +$1.63M | ﹤0.01% | 3144 |
|
|
2015
Q3 | $434K | Buy |
+27,206
| New | +$531K | ﹤0.01% | 3528 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Northern Trust's EVH Position: Q1 2026 in Review
Northern Trust reduced its Evolent Health (EVH) stake by 13% in Q1 2026, selling an estimated $427K and leaving 917,137 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2953.
Northern Trust first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $41.2M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Northern Trust held 917,137 shares of Evolent Health worth $2.09M as of Q1 2026.
- Northern Trust sold 134,698 Evolent Health shares in Q1 2026, an estimated $427K.
- Evolent Health made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2953 holding.
- Northern Trust first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
- Northern Trust's Evolent Health position peaked at $41.2M in Q4 2023.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.